Tirzepatide is a once-weekly injectable medication used primarily for type 2 diabetes and weight management. It is a dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, meaning it mimics the action of two natural gut hormones that regulate blood sugar, appetite, and insulin secretion.
🔹 Health Benefits of Tirzepatide:
Improves blood glucose control by increasing insulin and lowering glucagon in response to meals
Promotes significant weight loss by reducing appetite and slowing gastric emptying
May improve cardiovascular markers such as blood pressure, cholesterol, and inflammatory markers
Supports metabolic health, including improvements in insulin sensitivity and fat distribution
Reduces risk of diabetes complications when used in appropriate patients
✅ Who Might Benefit:
Adults with type 2 diabetes who need better glucose control
Patients with obesity or overweight (BMI ≥27) seeking medical weight loss
Individuals with insulin resistance or metabolic syndrome under medical supervision